PLN 7.45
(-0.67%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | -5.7 Million PLN | -84.9% |
2022 | 5.13 Million PLN | 47.83% |
2021 | 3.47 Million PLN | 11.21% |
2020 | 3.12 Million PLN | 47.7% |
2019 | 2.11 Million PLN | 23.72% |
2018 | 1.7 Million PLN | 102.01% |
2017 | 846.02 Thousand PLN | 78.83% |
2016 | 473.08 Thousand PLN | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 83 Thousand PLN | 974.38% |
2024 Q1 | 121 Thousand PLN | -67.99% |
2023 Q1 | 1.45 Million PLN | -17.24% |
2023 FY | 775 Thousand PLN | -84.9% |
2023 Q4 | 378 Thousand PLN | -73.06% |
2023 Q3 | 1.4 Million PLN | -14.03% |
2023 Q2 | 1.63 Million PLN | 12.16% |
2022 Q1 | 1.05 Million PLN | 11.09% |
2022 FY | 5.13 Million PLN | 47.83% |
2022 Q4 | 1.75 Million PLN | 44.33% |
2022 Q3 | 1.21 Million PLN | 10.13% |
2022 Q2 | 1.1 Million PLN | 5.13% |
2021 Q4 | 947 Thousand PLN | -8.68% |
2021 Q2 | 1.03 Million PLN | 125.82% |
2021 Q1 | 457 Thousand PLN | -85.37% |
2021 Q3 | 1.03 Million PLN | 0.48% |
2021 FY | 3.47 Million PLN | 11.21% |
2020 Q4 | 3.12 Million PLN | 2002770.51% |
2020 Q1 | -0.70 PLN | -100.0% |
2020 Q2 | 1009.00 PLN | 144242.86% |
2020 Q3 | -156.00 PLN | -115.46% |
2020 FY | 3.12 Million PLN | 47.7% |
2019 Q2 | 258.04 Thousand PLN | -24.49% |
2019 FY | 2.11 Million PLN | 23.72% |
2019 Q4 | 968.36 Thousand PLN | 77.28% |
2019 Q3 | 546.23 Thousand PLN | 111.68% |
2019 Q1 | 341.73 Thousand PLN | -54.2% |
2018 Q1 | 261.64 Thousand PLN | -42.02% |
2018 Q4 | 746.18 Thousand PLN | 161.23% |
2018 Q2 | 415.94 Thousand PLN | 58.97% |
2018 FY | 1.7 Million PLN | 102.01% |
2018 Q3 | 285.64 Thousand PLN | -31.33% |
2017 Q2 | 172.79 Thousand PLN | 0.0% |
2017 FY | 846.02 Thousand PLN | 78.83% |
2017 Q3 | 151.67 Thousand PLN | -12.22% |
2017 Q4 | 451.27 Thousand PLN | 197.53% |
2016 FY | 473.08 Thousand PLN | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Adiuvo Investments S.A. | 6.05 Million PLN | 194.203% |
Genomtec S.A. | 7.93 Million PLN | 171.893% |
Medicalgorithmics S.A. | 16.52 Million PLN | 134.528% |
Synektik Spólka Akcyjna | 83.04 Million PLN | 106.868% |